Structural Basis for Clinical Longevity of Carbapenem Antibiotics in the Face of Challenge by the Common Class A β-Lactamases from the Antibiotic-Resistant Bacteria
- 1 September 1998
- journal article
- Published by American Chemical Society (ACS) in Journal of the American Chemical Society
- Vol. 120 (38) , 9748-9752
- https://doi.org/10.1021/ja9818001
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Catalytic properties of class A β-lactamases: efficiency and diversityBiochemical Journal, 1998
- Nomenclature of TEM beta-lactamasesJournal of Antimicrobial Chemotherapy, 1997
- Impact of changing pathogens and antimicrobial susceptibility patterns in the treatment of serious infections in hospitalized patientsThe American Journal of Medicine, 1996
- Imipenem/CilastatinDrugs, 1996
- Mechanism of turnover of imipenem by the TEM .beta.-lactamase revisitedJournal of the American Chemical Society, 1995
- Hospital-acquired infections: diseases with increasingly limited therapies.Proceedings of the National Academy of Sciences, 1994
- Crystal structure of Escherichia coli TEM1 β‐lactamase at 1.8 Å resolutionProteins-Structure Function and Bioinformatics, 1993
- The Crisis in Antibiotic ResistanceScience, 1992
- The role of lysine-234 in .beta.-lactamase catalysis probed by site-directed mutagenesisBiochemistry, 1990
- Antibacterial Activity of Imipenem: The First Thienamycin AntibioticClinical Infectious Diseases, 1985